Novel peptide excipient RTP004 enhances the binding of botulinum neurotoxin type A cell binding domain HC to rat brain synaptosomes von Weisemann, Jasmin, Rummel, Andreas, Oliyai, Cecilia, Too, Priscilla, Joshi, Abhay

Volltext

Development of a cell-based potency assay for release and stability testing of drug substance and drug product von Smyth, Tyson, Petty, Lauren, Shih, Ai, Oliyai, Cecilia, Joshi, Abhay

Volltext

Revance's novel peptide excipient, RTP004, and its role in stabilizing daxibotulinumtoxinA (DAXI) against aggregation von Malmirchegini, Reza, Too, Priscilla, Oliyai, Cecilia, Joshi, Abhay

Volltext

Stabilizing effect of RTP004 on nonspecific surface adsorption in drug product manufacturing of daxibotulinumtoxinA (DAXI) von Smyth, Tyson, Oliyai, Cecilia, Joshi, Abhay

Volltext

Nonclinical overview of daxibotulinumtoxinA for injection to support registration for human use von Prawdzik, Gregg, Oliyai, Cecilia, Joshi, Abhay

Volltext

Chemical pathways of peptide degradation. VII: Solid state chemical instability of an aspartyl residue in a model hexapeptide von OLIYAI, C, PATEL, J. P, CARR, L, BORCHARDT, R. T

Volltext

FORMULATIONS FOR ANTI-C1Q ANTIBODIES von THAI, Khoi, OLIYAI, Cecilia

Volltext bestellen

N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin:  An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity von Fernandez, Anne-Marie, Van derpoorten, Kim, Dasnois, Luc, Lebtahi, Karim, Dubois, Vincent, Lobl, Thomas J, Gangwar, Sanjeev, Oliyai, Cecilia, Lewis, Evan R, Shochat, Dan, Trouet, André

Volltext

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer : Application to doxorubicin and preliminary in vitro and in vivo studies von TROUET, André, PASSIOUKOV, Alexandre, VAN DERPOORTEN, Kim, FERNANDEZ, Anne-Marie, ABARCA-QUINONES, Jorge, BAURAIN, Roger, LOBL, Thomas J, OLIYAI, Cecilia, SHOCHAT, Dan, DUBOIS, Vincent

Volltext

Chemical pathways of peptide degradation. IV: Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide von OLIYAI, C, BORCHARDT, R. T

Volltext

Chemical pathways of peptide degradation. VI: Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides von OLIYAI, C, BORCHARDT, R. T

Volltext

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: In vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity von DUBOIS, Vincent, DASNOIS, Luc, SHOCHAT, Dan, YARRANTON, Geoffrey T, TROUET, André, LEBTAHI, Karim, COLLOT, Francoise, HEYLEN, Nathalie, HAVAUX, Nathalie, FERNANDEZ, Anne-Marie, LOBL, Thomas J, OLIYAI, Cecilia, NIEDER, Matthew

Volltext